Dr. Drew links GLP-1 drugs to Nick Reiner's tragic case

Dr. Drew Pinsky appeared on TMZ Live to discuss how weight-loss drugs like Ozempic could have potentially altered the path of Nick Reiner, who murdered his parents amid medication changes. He highlighted the delicate balance of prescribing such drugs alongside anti-psychotics. The insight ties into TMZ's new documentary on the Reiner murders.

Oh, honey, the tea on this one is piping hot and heartbreaking. Nick Reiner's story took a dark turn when his weight gain from anti-psychotic meds spiraled him into chaos, leading to the unthinkable murders of his parents, Rob and Michele Reiner. As TMZ's explosive new doc, "The Reiner Murders: What Really Happened," lays out, Nick was stable on his cocktail of drugs until just a month before the killings. That's when he complained to docs about packing on pounds—a super common side effect, apparently. They switched up his meds, and boom: sources say the new combo hurled him into an erratic, dangerous state, culminating in a full break from reality. 😱

Enter Dr. Drew, the no-nonsense doc who spilled on "TMZ Live" Monday. He dropped that Nick "likely would have benefited from being prescribed weight-loss drugs to counteract" that pesky side effect. We're talking GLP-1s like Ozempic and Mounjaro, which younger psychiatrists are now slinging to balance out the bloat from psych meds. But Drew didn't sugarcoat it: "it's a delicate balance." In Nick's case? These drugs "may have helped," potentially keeping everything steady without the med swap. Who knows—maybe Rob, Michele, and Nick would all still be here, living their lives. 💔

It's a messy reminder of how thin the line is between stability and tragedy in mental health treatment. Catch the full interview on "TMZ Live" and stream the doc on Hulu for all the gut-wrenching details. So, is Big Pharma's next frontier in psych care a game-changer... or just another risky gamble?

Labaran da ke da alaƙa

Realistic illustration contrasting social stigma: neutral for overweight, positive for exercise weight loss, negative for Ozempic users.
Hoton da AI ya samar

Study finds people who use Ozempic-like drugs for weight loss face added stigma

An Ruwaito ta hanyar AI Hoton da AI ya samar An Binciki Gaskiya

People who lose weight using GLP-1 medications such as Ozempic and Wegovy may be judged more negatively than those who lose weight through diet and exercise — and even more negatively than people who do not lose weight at all — according to a new study led by Rice University psychologist Erin Standen.

Teddi Mellencamp, the Real Housewives of Beverly Hills alum, spilled on her podcast that she begged her doctor for GLP-1 weight-loss drugs while battling cancer. She gained weight from steroids but got shut down. Joking about the irony, she quipped about living her best life without the meds.

An Ruwaito ta hanyar AI

Young Indians are turning to diabetes drugs Ozempic and Mounjaro for rapid weight loss before weddings and job interviews, as experts warn of cosmetic misuse, grey market dangers, and rising lookism. These GLP-1 drugs are meant for obesity and diabetes, not vanity purposes, doctors emphasize.

Wannan shafin yana amfani da cookies

Muna amfani da cookies don nazari don inganta shafin mu. Karanta manufar sirri mu don ƙarin bayani.
Ƙi